{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:24:45Z","timestamp":1787318685076,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1124\/jpet.109.151142","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T23:05:59Z","timestamp":1235516759000},"page":"827-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Carisoprodol-Mediated Modulation of GABAA Receptors: In Vitro and in Vivo Studies"],"prefix":"10.1016","volume":"329","author":[{"given":"Lorie A.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Gatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy L.","family":"Bell-Horner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn H.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.151142_bib1","doi-asserted-by":"crossref","unstructured":"Amin J (1999) A single hydrophobic residue confers barbiturate sensitivity to gamma-aminobutryic acid type C receptor. Mol Pharmacol 55: 411-423.","DOI":"10.1016\/S0026-895X(24)12165-7"},{"key":"10.1124\/jpet.109.151142_bib2","unstructured":"Amin J and Weiss DS (1994) Homomeric rho 1 GABA channels: activation properties and domains. Receptors Channels 2: 227-236."},{"key":"10.1124\/jpet.109.151142_bib3","doi-asserted-by":"crossref","unstructured":"Ator NA and Griffiths RR (1989) Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam. Psychopharmacology 98: 20-30.","DOI":"10.1007\/BF00442001"},{"key":"10.1124\/jpet.109.151142_bib4","doi-asserted-by":"crossref","unstructured":"Bossoni G, Colasanti P, Bianchi S, Riva M, and Usardi MM (1979) Influence of species specificity on gastric emptying rate and blood levels of carisoprodol. Pharmacol Res Commun 11: 693-702.","DOI":"10.1016\/S0031-6989(79)80059-4"},{"key":"10.1124\/jpet.109.151142_bib5","doi-asserted-by":"crossref","unstructured":"Bramness JG, M\u00f8rland J, S\u00f8rlid HK, Rudberg N, and Jacobsen D (2005) Carisoprodol intoxications and serotonergic features. Clin Toxicol (Phila) 43: 39-45.","DOI":"10.1081\/CLT-200045020"},{"key":"10.1124\/jpet.109.151142_bib6","doi-asserted-by":"crossref","unstructured":"Bramness JG, Skurtveit S, and M\u00f8rland J (2004) Impairment due to intake of carisoprodol. Drug Alcohol Depend 74: 311-318.","DOI":"10.1016\/j.drugalcdep.2004.01.007"},{"key":"10.1124\/jpet.109.151142_bib7","unstructured":"Chan PC (2000) NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344\/N rats and B6C3F1 mice. Toxic Rep Ser 56: 1-G14."},{"key":"10.1124\/jpet.109.151142_bib8","doi-asserted-by":"crossref","unstructured":"Dal\u00e9n P, Alvan G, Wakelkamp M, and Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6: 387-394.","DOI":"10.1097\/00008571-199610000-00002"},{"key":"10.1124\/jpet.109.151142_bib9","doi-asserted-by":"crossref","unstructured":"De Vry J and Slangen JL (1986) Differential interactions between chlordiazepoxide, pentobarbital and benzodiazepine antagonists Ro 15\u20131788 and CGS 8216 in a drug discrimination procedure. Pharmacol Biochem Behav 24: 999-1005.","DOI":"10.1016\/0091-3057(86)90448-X"},{"key":"10.1124\/jpet.109.151142_bib10","unstructured":"Drug Abuse Warning Network (2000) Emergency Room Data. DAWN Series D-20, DHHS Publication No. (SMA) 02-3634, Rockville, MD."},{"key":"10.1124\/jpet.109.151142_bib11","unstructured":"Elder NC (1991) Abuse of skeletal muscle relaxants. Am Fam Physician 44: 1223-1226."},{"key":"10.1124\/jpet.109.151142_bib12","doi-asserted-by":"crossref","unstructured":"Elenbaas JK (1980) Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm 37: 1313-1323.","DOI":"10.1093\/ajhp\/37.10.1313"},{"key":"10.1124\/jpet.109.151142_bib13","unstructured":"Ellenhorn MJ and Barceloux DG (1988) Medical Toxicology: Diagnosis and Treatment of Human Poisoning, Elsevier Science Publishing, New York."},{"key":"10.1124\/jpet.109.151142_bib14","doi-asserted-by":"crossref","unstructured":"Goldberg D (1969) Carisoprodol toxicity. Mil Med 134: 597-601.","DOI":"10.1093\/milmed\/134.8.597"},{"key":"10.1124\/jpet.109.151142_bib15","doi-asserted-by":"crossref","unstructured":"Gonzales EB, Bell-Horner CL, de la Cruz MA, Ferrendelli JA, Covey DF, and Dillon GH (2004) (2004) Enantiomeric selectivity of the interaction of \u03b1-benzyl-\u03b1-methyl-\u03b3-butyrolactone-mediated modulation of anticonvulsant activity and GABAA receptor function. J Pharmacol Exp Ther 309: 677-683.","DOI":"10.1124\/jpet.103.063008"},{"key":"10.1124\/jpet.109.151142_bib16","doi-asserted-by":"crossref","unstructured":"Hawkinson JE, Drewe JA, Kimbrough CL, Chen JS, Hogenkamp DJ, Lan NC, Gee KW, Shen KZ, Whittemore ER, and Woodward RM (1996) 3 alpha-Hydroxy-3 beta-trifluoromethyl-5 alpha-pregnan-20-one (Co 2\u20131970): a partial agonist at the neuroactive steroid site of the gamma-aminobutyric acid A receptor. Mol Pharmacol 49: 897-906.","DOI":"10.1016\/S0026-895X(25)09083-2"},{"key":"10.1124\/jpet.109.151142_bib17","doi-asserted-by":"crossref","unstructured":"Herling S and Shannon HE (1982) Ro 15-1788 antagonizes the discriminative stimulus effects of diazepam in rats but not similar effects of pentobarbital. Life Sci 31: 2105-2112.","DOI":"10.1016\/0024-3205(82)90102-3"},{"key":"10.1124\/jpet.109.151142_bib18","doi-asserted-by":"crossref","unstructured":"Huang RQ, Bell-Horner CL, Dibas MI, Covey DF, Drewe JA, and Dillon GH (2001) Pentylenetetrazole-induced inhibition of recombinant GABAA receptors: mechanism and site of action. J Pharmacol Exp Ther 298: 986-995.","DOI":"10.1016\/S0022-3565(24)29466-0"},{"key":"10.1124\/jpet.109.151142_bib19","unstructured":"Huang RQ, Gonzales EB, and Dillon GH (2006) GABAA receptors: structure, function and modulation, in Biological and Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies (Arias H ed), pp 171-198, Research Signpost, Kerala, India."},{"key":"10.1124\/jpet.109.151142_bib20","unstructured":"Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC."},{"key":"10.1124\/jpet.109.151142_bib21","doi-asserted-by":"crossref","unstructured":"Kato R and Takanaka A (1968) Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats. Jpn J Pharmacol 18: 389-396.","DOI":"10.1254\/jjp.18.389"},{"key":"10.1124\/jpet.109.151142_bib22","unstructured":"Kenakin T (1997) Pharmacologic Analysis of Drug-Receptor Interaction, Lippincott Williams & Wilkins, Philadelphia, PA."},{"key":"10.1124\/jpet.109.151142_bib23","unstructured":"Krimmer EC, Barry H III, and Coltrin D (1978) Antagonism of pentobarbital discriminative stimulus by bemegride in immobilized rats, in Stimulus Properties of Drugs: Ten Years of Progress (Colpaert FC and Rosecrans JA eds) p 167, Elsevier\/North Holland Biomedical Press, Amsterdam."},{"key":"10.1124\/jpet.109.151142_bib24","doi-asserted-by":"crossref","unstructured":"Littrell RA, Hayes LR, and Stillner V (1993) Carisoprodol (Soma): a new and cautious perspective on an old agent. South Med J 86: 753-756.","DOI":"10.1097\/00007611-199307000-00006"},{"key":"10.1124\/jpet.109.151142_bib25","doi-asserted-by":"crossref","unstructured":"Luo X, Pietrobon R, Curtis LH, and Hey LA (2004) Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the united states. Spine 29: E531-E537.","DOI":"10.1097\/01.brs.0000146453.76528.7c"},{"key":"10.1124\/jpet.109.151142_bib26","doi-asserted-by":"crossref","unstructured":"McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, et al. (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3: 587-592.","DOI":"10.1038\/75761"},{"key":"10.1124\/jpet.109.151142_bib27","doi-asserted-by":"crossref","unstructured":"Morse RM and Chua L (1978) Carisoprodol dependence: a case report. Am J Drug Alcohol Abuse 5: 527-530.","DOI":"10.3109\/00952997809007027"},{"key":"10.1124\/jpet.109.151142_bib28","doi-asserted-by":"crossref","unstructured":"Olsen H, Koppang E, Alvan G, and M\u00f8rland J (1994) Carisoprodol elimination in humans. Ther Drug Monit 16: 337-340.","DOI":"10.1097\/00007691-199408000-00001"},{"key":"10.1124\/jpet.109.151142_bib29","doi-asserted-by":"crossref","unstructured":"Reeves RR, Pinkofsky HB, and Carter OS (1997) Carisoprodol: a drug of continuing abuse. J Am Osteopath Assoc 97: 723-724.","DOI":"10.7556\/jaoa.1997.97.12.723"},{"key":"10.1124\/jpet.109.151142_bib30","doi-asserted-by":"crossref","unstructured":"Rho JM, Donevan SD, and Rogawski MA (1996) Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. J Physiol 497: 509-522.","DOI":"10.1113\/jphysiol.1996.sp021784"},{"key":"10.1124\/jpet.109.151142_bib31","doi-asserted-by":"crossref","unstructured":"Rho JM, Donevan SD, and Rogawski MA (1997) Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther 280: 1383-1391.","DOI":"10.1016\/S0022-3565(24)36535-8"},{"key":"10.1124\/jpet.109.151142_bib32","doi-asserted-by":"crossref","unstructured":"Roberge RJ, Lin E, and Krenzelok EP (2000) Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 18: 61-64.","DOI":"10.1016\/S0736-4679(99)00177-8"},{"key":"10.1124\/jpet.109.151142_bib33","unstructured":"Robertson MD and Marinetti LJ (2003) Carisoprodol: effects on human performance and behavior. Forensic Sci Rev 15: 1-9."},{"key":"10.1124\/jpet.109.151142_bib34","doi-asserted-by":"crossref","unstructured":"Roth BA, Vinson DR, and Kim S (1998) Carisoprodol-induced myoclonic encephalopathy. J Toxicol Clin Toxicol 36: 609-612.","DOI":"10.3109\/15563659809028058"},{"key":"10.1124\/jpet.109.151142_bib35","doi-asserted-by":"crossref","unstructured":"Rudolph U, Crestani F, Benke D, Br\u00fcnig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, and M\u00f6hler H (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401: 796-800.","DOI":"10.1038\/44579"},{"key":"10.1124\/jpet.109.151142_bib36","doi-asserted-by":"crossref","unstructured":"Rust GS, Hatch R, and Gums JG (1993) Carisoprodol as a drug of abuse. Arch Fam Med 2: 429-432.","DOI":"10.1001\/archfami.2.4.429"},{"key":"10.1124\/jpet.109.151142_bib37","doi-asserted-by":"crossref","unstructured":"Schechter MD (1984) Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat. Prog Neuropsychopharmacol Biol Psychiatry 8: 359-364.","DOI":"10.1016\/0278-5846(84)90110-6"},{"key":"10.1124\/jpet.109.151142_bib38","unstructured":"van der Kleijn E (1969) Kinetics of distribution and metabolism of ataractics of the meprobamate-group in mice. Arch Int Pharmacodyn Ther 178: 457-480."},{"key":"10.1124\/jpet.109.151142_bib39","doi-asserted-by":"crossref","unstructured":"Williams KL, Tucker JB, White G, Weiss DS, Ferrendelli JA, Covey DF, Krause JE, and Rothman SM (1997) Lactone modulation of the gamma-aminobutyric acid A receptor: evidence for a positive modulatory site. Mol Pharmacol 52: 114-119.","DOI":"10.1124\/mol.52.1.114"},{"key":"10.1124\/jpet.109.151142_bib40","doi-asserted-by":"crossref","unstructured":"Woolverton WL and Nader MA (1995) Effects of several benzodiazepines, alone and in combination with flumazenil, in rhesus monkeys trained to discriminate pentobarbital from saline. Psychopharmacology 122: 230-236.","DOI":"10.1007\/BF02246544"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524384253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524384253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.151142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:29:17Z","timestamp":1739996957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524384253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0022356524384253"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.151142","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carisoprodol-Mediated Modulation of GABAA Receptors: In Vitro and in Vivo Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.151142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}